Template:Pneumonia Antibiotics: Difference between revisions
Ostermayer (talk | contribs) |
|||
| Line 13: | Line 13: | ||
===Inpatient=== | ===Inpatient=== | ||
*Monotherapy or combination therapy is acceptable. Combination therapy includes a cephalosporin and macrolide targeting atypicals and Strep Pneumonia <ref>Chokshi R, Restrepo MI, Weeratunge N, Frei CR, Anzueto A, Mortensen EM. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. Jul 2007;26(7):447-51</ref> | |||
====Community-acquired PNA==== | ====Community-acquired PNA==== | ||
#[[Levofloxacin]] 750mg QD x5d OR | #[[Levofloxacin]] 750mg QD x5d OR | ||
#[[Moxifloxacin]] 400mg QD x7-14d OR | #[[Moxifloxacin]] 400mg QD x7-14d OR | ||
#3rd generation [[cephalosporin]] AND [[azithromycin]] | #3rd generation [[cephalosporin]] AND [[azithromycin]] OR [[doxycycline]] | ||
====Health Care-associated PNA==== | ====Health Care-associated PNA==== | ||
Revision as of 15:31, 30 November 2014
Outpatient, community-acquired PNA
Healthy
- Clarithromycin XL 1000mg PO QD x7d OR
- Azithromycin 500mg PO day 1, 250mg on days 2-5 OR
- Doxycycline 100mg BID x 10-14d (2nd line choice)
Unhealthy
- Chronic heart, lung, liver, or renal disease; DM, alcholism, malignancy. Add
- Levofloxacin 750mg QD x5d OR
- Moxifloxacin 400mg QD x7-14d OR
- Amoxicillin/Clavulanate 2g BID AND Azithromycin 500mg day 1, 250mg days 2-5 OR Doxy
- 3rd generation cephalosporin AND Azithromycin or Doxycycline
Inpatient
- Monotherapy or combination therapy is acceptable. Combination therapy includes a cephalosporin and macrolide targeting atypicals and Strep Pneumonia [1]
Community-acquired PNA
- Levofloxacin 750mg QD x5d OR
- Moxifloxacin 400mg QD x7-14d OR
- 3rd generation cephalosporin AND azithromycin OR doxycycline
Health Care-associated PNA
- 3-drug regimen recommended
- (Cefepime 1-2gm q8-12h OR ceftazidime 2gm q8h) + cipro 400mg q8h + vanco 15mg/kg q12 OR
- Imipenem 500mg q6hr + cipro 400mg q8hr + vanco 15mg/kg q12 OR
- Piperacillin-Tazobactam 4.5gm q6h + cipro 400mg q8h + vanco 15mg/kg q12
ICU, low risk of pseudomonas
- Ceftriaxone 1gm IV and Azithromycin 500mg IV OR
- Ceftriaxone 1gm IV and (moxifloxacin 400mg IV or levofloxacin 750mg IV)
- Penicillin allergy
- (Moxifloxacin or levofloxacin) + (aztreonam 1-2gm IV or clindamycin 600mg IV)
ICU, risk of pseudomonas
- Cefipime, Imipenem, OR Piperacillin/Tazobactam + IV cipro/levo
- Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin
- Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo
- ↑ Chokshi R, Restrepo MI, Weeratunge N, Frei CR, Anzueto A, Mortensen EM. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. Jul 2007;26(7):447-51
